AmerisourceBergen (NYSE:ABC) CFO Tim G. Guttman sold 11,600 shares of the company’s stock in a transaction dated Thursday, April 5th. The shares were sold at an average price of $85.60, for a total value of $992,960.00. Following the completion of the sale, the chief financial officer now owns 56,472 shares of the company’s stock, valued at approximately $4,834,003.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of AmerisourceBergen stock opened at $85.41 on Friday. AmerisourceBergen has a 1 year low of $71.90 and a 1 year high of $106.27. The stock has a market capitalization of $19,194.68, a price-to-earnings ratio of 14.53, a price-to-earnings-growth ratio of 1.31 and a beta of 1.06. The company has a quick ratio of 0.50, a current ratio of 0.95 and a debt-to-equity ratio of 1.61.
AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.35 by $0.20. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The company had revenue of $40.47 billion during the quarter, compared to the consensus estimate of $40.42 billion. During the same period in the prior year, the company earned $1.36 earnings per share. The company’s revenue for the quarter was up 6.0% compared to the same quarter last year. research analysts predict that AmerisourceBergen will post 6.57 EPS for the current fiscal year.
A number of equities research analysts recently commented on ABC shares. TheStreet upgraded AmerisourceBergen from a “c” rating to a “b” rating in a report on Tuesday, February 6th. Zacks Investment Research upgraded AmerisourceBergen from a “hold” rating to a “buy” rating and set a $105.00 price objective for the company in a report on Wednesday, January 3rd. Leerink Swann set a $105.00 price objective on AmerisourceBergen and gave the company a “buy” rating in a report on Tuesday, January 2nd. Goldman Sachs upgraded AmerisourceBergen from a “neutral” rating to a “buy” rating in a report on Friday, December 15th. Finally, Cowen set a $107.00 price objective on AmerisourceBergen and gave the company a “buy” rating in a report on Tuesday, December 12th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $102.72.
Institutional investors have recently made changes to their positions in the business. Macquarie Group Ltd. grew its holdings in shares of AmerisourceBergen by 4.4% during the third quarter. Macquarie Group Ltd. now owns 21,214 shares of the company’s stock worth $1,754,000 after buying an additional 894 shares in the last quarter. Schroder Investment Management Group grew its holdings in shares of AmerisourceBergen by 495.5% during the third quarter. Schroder Investment Management Group now owns 13,100 shares of the company’s stock worth $1,061,000 after buying an additional 10,900 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of AmerisourceBergen by 4.2% during the third quarter. Dimensional Fund Advisors LP now owns 789,102 shares of the company’s stock worth $65,290,000 after buying an additional 31,961 shares in the last quarter. Pinebridge Investments L.P. grew its holdings in shares of AmerisourceBergen by 215.2% during the third quarter. Pinebridge Investments L.P. now owns 11,656 shares of the company’s stock worth $965,000 after buying an additional 7,958 shares in the last quarter. Finally, Stifel Financial Corp grew its holdings in shares of AmerisourceBergen by 4.4% during the third quarter. Stifel Financial Corp now owns 48,303 shares of the company’s stock worth $3,996,000 after buying an additional 2,038 shares in the last quarter. Institutional investors own 67.31% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Insider Selling: AmerisourceBergen (ABC) CFO Sells 11,600 Shares of Stock” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/04/08/insider-selling-amerisourcebergen-abc-cfo-sells-11600-shares-of-stock.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.